TINA MICHELLE LAWSON

Allopathic & Osteopathic Physicians|Family Medicine KOKOMO, IN NPI 1528044161

General Payments — all program years on this page

$4,675.37

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 193
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $815.84 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $815.8418

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Abbott Laboratories $417.506
Corcept Therapeutics $172.565
GlaxoSmithKline, LLC. $121.181
Exact Sciences Corporation $48.953
Grifols USA, LLC $24.131
DEXCOM, INC. $16.171
ABBVIE INC. $15.351

By program year

Program yearAmountRecords
2018 $2,243.42116
2019 $1,031.5049
2020 $98.491
2021 $120.422
2023 $365.707
2024 $815.8418

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104144754 ABBVIE INC. $15.35 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114750552 Exact Sciences Corporation $14.77 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114750558 Exact Sciences Corporation $17.88 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114750563 Exact Sciences Corporation $16.30 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115932765 GlaxoSmithKline, LLC. $121.18 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117731526 Corcept Therapeutics $8.25 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117731542 Corcept Therapeutics $13.65 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117731546 Corcept Therapeutics $17.22 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117731550 Corcept Therapeutics $5.97 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117731612 Corcept Therapeutics $127.47 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124718834 Grifols USA, LLC $24.13 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125108544 Abbott Laboratories $0.62 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125108546 Abbott Laboratories $8.36 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125108548 Abbott Laboratories $6.11 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125108550 Abbott Laboratories $127.22 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125108552 Abbott Laboratories $165.18 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125108554 Abbott Laboratories $110.01 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153341315 Dexcom, Inc. $16.17 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.